Welch & Forbes’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.8M | Sell |
83,322
-5,612
| -6% | -$2.69M | 0.51% | 51 |
|
|
2026
Q1 | $43.7M | Sell |
88,934
-150
| -0.2% | -$81.4K | 0.57% | 53 |
|
|
2025
Q4 | $51.6M | Sell |
89,084
-642
| -0.7% | -$363K | 0.63% | 46 |
|
|
2025
Q3 | $43.5M | Sell |
89,726
-1,388
| -2% | -$646K | 0.52% | 54 |
|
|
2025
Q2 | $36.9M | Sell |
91,114
-655
| -0.7% | -$274K | 0.46% | 60 |
|
|
2025
Q1 | $45.7M | Buy |
91,769
+738
| +0.8% | +$400K | 0.6% | 47 |
|
|
2024
Q4 | $47.4M | Sell |
91,031
-3,246
| -3% | -$1.78M | 0.61% | 44 |
|
|
2024
Q3 | $58.3M | Buy |
94,277
+384
| +0.4% | +$227K | 0.74% | 43 |
|
|
2024
Q2 | $50.7M | Buy |
93,893
+25
| +0% | +$14.3K | 0.68% | 43 |
|
|
2024
Q1 | $54.6M | Buy |
93,868
+6,231
| +7% | +$3.5M | 0.75% | 41 |
|
|
2023
Q4 | $46.5M | Buy |
87,637
+66
| +0.1% | +$31.9K | 0.7% | 43 |
|
|
2023
Q3 | $44.3M | Buy |
87,571
+3,586
| +4% | +$1.91M | 0.73% | 43 |
|
|
2023
Q2 | $43.8M | Buy |
83,985
+1,642
| +2% | +$886K | 0.69% | 45 |
|
|
2023
Q1 | $47.5M | Buy |
82,343
+1,274
| +2% | +$718K | 0.8% | 38 |
|
|
2022
Q4 | $44.6M | Sell |
81,069
-307
| -0.4% | -$163K | 0.8% | 38 |
|
|
2022
Q3 | $41.3M | Buy |
81,376
+758
| +0.9% | +$424K | 0.81% | 39 |
|
|
2022
Q2 | $43.8M | Buy |
80,618
+2,099
| +3% | +$1.16M | 0.8% | 40 |
|
|
2022
Q1 | $46.4M | Buy |
78,519
+2,392
| +3% | +$1.37M | 0.73% | 41 |
|
|
2021
Q4 | $50.8M | Buy |
76,127
+302
| +0.4% | +$189K | 0.76% | 39 |
|
|
2021
Q3 | $43.3M | Buy |
75,825
+2,684
| +4% | +$1.47M | 0.72% | 40 |
|
|
2021
Q2 | $36.9M | Buy |
73,141
+3,210
| +5% | +$1.51M | 0.62% | 47 |
|
|
2021
Q1 | $31.9M | Buy |
69,931
+2,008
| +3% | +$958K | 0.59% | 50 |
|
|
2020
Q4 | $31.6M | Buy |
67,923
+482
| +0.7% | +$226K | 0.62% | 46 |
|
|
2020
Q3 | $29.8M | Buy |
67,441
+1,347
| +2% | +$557K | 0.64% | 46 |
|
|
2020
Q2 | $23.9M | Buy |
66,094
+3,294
| +5% | +$1.1M | 0.56% | 52 |
|
|
2020
Q1 | $17.8M | Buy |
62,800
+2,676
| +4% | +$844K | 0.5% | 61 |
|
|
2019
Q4 | $19.5M | Buy |
60,124
+725
| +1% | +$220K | 0.43% | 68 |
|
|
2019
Q3 | $17.3M | Buy |
59,399
+1,755
| +3% | +$503K | 0.41% | 70 |
|
|
2019
Q2 | $16.9M | Buy |
57,644
+2,371
| +4% | +$653K | 0.41% | 68 |
|
|
2019
Q1 | $15.1M | Buy |
55,273
+1,990
| +4% | +$495K | 0.38% | 76 |
|
|
2018
Q4 | $11.9M | Buy |
53,283
+1,855
| +4% | +$435K | 0.34% | 80 |
|
|
2018
Q3 | $12.6M | Buy |
51,428
+3,473
| +7% | +$799K | 0.3% | 91 |
|
|
2018
Q2 | $9.93M | Buy |
47,955
+35,913
| +298% | +$7.62M | 0.26% | 95 |
|
|
2018
Q1 | $2.49M | Sell |
12,042
-11
| -0.1% | -$2.31K | 0.06% | 163 |
|
|
2017
Q4 | $2.29M | Sell |
12,053
-95
| -0.8% | -$18.2K | 0.06% | 159 |
|
|
2017
Q3 | $2.3M | Hold |
12,148
| – | – | 0.06% | 162 |
|
|
2017
Q2 | $2.12M | Buy |
12,148
+34
| +0.3% | +$5.71K | 0.06% | 163 |
|
|
2017
Q1 | $1.86M | Sell |
12,114
-334
| -3% | -$51K | 0.05% | 168 |
|
|
2016
Q4 | $1.76M | Buy |
12,448
+1,310
| +12% | +$193K | 0.05% | 170 |
|
|
2016
Q3 | $1.77M | Sell |
11,138
-265
| -2% | -$40.8K | 0.06% | 147 |
|
|
2016
Q2 | $1.69M | Sell |
11,403
-200
| -2% | -$29.5K | 0.05% | 169 |
|
|
2016
Q1 | $1.64M | Buy |
11,603
+262
| +2% | +$35.1K | 0.05% | 170 |
|
|
2015
Q4 | $1.61M | Sell |
11,341
-1,221
| -10% | -$163K | 0.05% | 169 |
|
|
2015
Q3 | $1.54M | Sell |
12,562
-423
| -3% | -$55.1K | 0.05% | 177 |
|
|
2015
Q2 | $1.69M | Buy |
12,985
+3,350
| +35% | +$437K | 0.05% | 173 |
|
|
2015
Q1 | $1.29M | Sell |
9,635
-202
| -2% | -$26K | 0.04% | 195 |
|
|
2014
Q4 | $1.23M | Sell |
9,837
-229
| -2% | -$27.8K | 0.04% | 201 |
|
|
2014
Q3 | $1.23M | Sell |
10,066
-1,440
| -13% | -$175K | 0.04% | 204 |
|
|
2014
Q2 | $1.36M | Buy |
11,506
+840
| +8% | +$98.9K | 0.04% | 182 |
|
|
2014
Q1 | $1.28M | Buy |
10,666
+1,950
| +22% | +$232K | 0.04% | 193 |
|
|
2013
Q4 | $970K | Buy |
8,716
+150
| +2% | +$14.9K | 0.03% | 201 |
|
|
2013
Q3 | $790K | Buy |
8,566
+1,176
| +16% | +$106K | 0.03% | 216 |
|
|
2013
Q2 | $625K | Buy |
+7,390
| New | +$615K | 0.02% | 215 |
|
Other funds holding TMO
Welch & Forbes's TMO Position: Q2 2026 in Review
Welch & Forbes reduced its Thermo Fisher Scientific (TMO) stake by 6.3% in Q2 2026, selling an estimated $2.69M and leaving 83,322 shares worth $41.8M. The position accounts for 0.51% of the portfolio, ranked #51.
Welch & Forbes first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $58.3M in Q3 2024. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Welch & Forbes held 83,322 shares of Thermo Fisher Scientific worth $41.8M as of Q2 2026.
- Welch & Forbes sold 5,612 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.69M.
- Thermo Fisher Scientific made up 0.51% of Welch & Forbes's portfolio in Q2 2026, its #51 holding.
- Welch & Forbes first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Welch & Forbes's Thermo Fisher Scientific position peaked at $58.3M in Q3 2024.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Welch & Forbes's 13F filing for Q2 2026, filed 30 Jul 2026.